Corrigendum to ABCB5+ mesenchymal stromal cells facilitate complete and durable wound closure in recessive dystrophic epidermolysis bullosa [Cytotherapy 25 (2023) 782–788/1562]
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Cytotherapy. - 25, 9 (2023) , 1016, ISSN: 1477-2566
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2023
- Urheber
-
Dieter, Kathrin
Niebergall-Roth, Elke
Daniele, Cristina
Fluhr, Silvia
Frank, Natasha Y.
Ganss, Christoph
Kiritsi, Dimitra
McGrath, John A.
Tolar, Jakub
Frank, Markus H.
Kluth, Mark A.
- DOI
-
10.1016/j.jcyt.2023.06.001
- URN
-
urn:nbn:de:bsz:25-freidok-2383145
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dieter, Kathrin
- Niebergall-Roth, Elke
- Daniele, Cristina
- Fluhr, Silvia
- Frank, Natasha Y.
- Ganss, Christoph
- Kiritsi, Dimitra
- McGrath, John A.
- Tolar, Jakub
- Frank, Markus H.
- Kluth, Mark A.
- Universität
Entstanden
- 2023
Ähnliche Objekte (12)
Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers
Research in practice: towards deciphering the role of epidermal proteases in recessive dystrophic epidermolysis bullosa progression
Clinical trial of ABCB5-positive mesenchymal stem cells for recessive dystrophic epidermolysis bullosa
STAT3 targeting in dystrophic epidermolysis bullosa
Forschen für die Praxis: Die Rolle epidermaler Proteasen in der Progression der rezessiven dystrophen Epidermolysis bullosa : = Research in practice: Towards deciphering the role of epidermal proteases in recessive dystrophic epidermolysis bullosa progression
Treatment of Epidermolysis bullosa acquisita with dupilumab
Dupilumab zur Behandlung der Epidermolysis bullosa acquisita
Recent advances in understanding and managing epidermolysis bullosa
ABCB5+ mesenchymal stromal cells facilitate complete and durable wound closure in recessive dystrophic epidermolysis bullosa
Betulin-based oleogel to improve wound healing in dystrophic epidermolysis bullosa: a prospective controlled proof-of-concept study
Postzygotic mosaicism in genetic skin disorders : causes and pathogenetic mechanisms
Dupilumab verbessert Juckreiz und Blasenbildung bei verschiedenen Subtypen der Epidermolysis bullosa : = Dupilumab improves itch and blistering in different subtypes of epidermolysis bullosa
Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers
Research in practice: towards deciphering the role of epidermal proteases in recessive dystrophic epidermolysis bullosa progression
Clinical trial of ABCB5-positive mesenchymal stem cells for recessive dystrophic epidermolysis bullosa
STAT3 targeting in dystrophic epidermolysis bullosa
Forschen für die Praxis: Die Rolle epidermaler Proteasen in der Progression der rezessiven dystrophen Epidermolysis bullosa : = Research in practice: Towards deciphering the role of epidermal proteases in recessive dystrophic epidermolysis bullosa progression
Treatment of Epidermolysis bullosa acquisita with dupilumab
Dupilumab zur Behandlung der Epidermolysis bullosa acquisita
Recent advances in understanding and managing epidermolysis bullosa
ABCB5+ mesenchymal stromal cells facilitate complete and durable wound closure in recessive dystrophic epidermolysis bullosa
Betulin-based oleogel to improve wound healing in dystrophic epidermolysis bullosa: a prospective controlled proof-of-concept study
Postzygotic mosaicism in genetic skin disorders : causes and pathogenetic mechanisms
Dupilumab verbessert Juckreiz und Blasenbildung bei verschiedenen Subtypen der Epidermolysis bullosa : = Dupilumab improves itch and blistering in different subtypes of epidermolysis bullosa
Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers
Research in practice: towards deciphering the role of epidermal proteases in recessive dystrophic epidermolysis bullosa progression
Clinical trial of ABCB5-positive mesenchymal stem cells for recessive dystrophic epidermolysis bullosa
STAT3 targeting in dystrophic epidermolysis bullosa
Forschen für die Praxis: Die Rolle epidermaler Proteasen in der Progression der rezessiven dystrophen Epidermolysis bullosa : = Research in practice: Towards deciphering the role of epidermal proteases in recessive dystrophic epidermolysis bullosa progression
Treatment of Epidermolysis bullosa acquisita with dupilumab
Dupilumab zur Behandlung der Epidermolysis bullosa acquisita
Recent advances in understanding and managing epidermolysis bullosa
ABCB5+ mesenchymal stromal cells facilitate complete and durable wound closure in recessive dystrophic epidermolysis bullosa
Betulin-based oleogel to improve wound healing in dystrophic epidermolysis bullosa: a prospective controlled proof-of-concept study
Postzygotic mosaicism in genetic skin disorders : causes and pathogenetic mechanisms